Search clinical trials for: LCZ696 (sacubitril/valsartan)
Total 506 results
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionBelgium, Estonia, Denmark, Greece, United Kingdom, Germany, Latvia, Lithuania, Spain, Netherlands, Bulgaria, Finland, Poland, Czechia, Iceland, Sweden, France, Ireland, Norway
-
University Hospital, MontpellierCompletedChronic Heart Failure | Sleep Apnea SyndromeFrance
-
Novartis PharmaceuticalsCompletedHeart Failure, Reduced Ejection FractionUnited States
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States, Canada
-
Novartis PharmaceuticalsTerminatedHeart Failure With Preserved Ejection Fraction (HFpEF)Japan
-
Mark LedwidgeThe Heartbeat TrustActive, not recruitingHypertension | Atrial Remodeling | Cardiovascular Morbidity | Myocardial Dysfunction | Atrial Arrhythmia | Left Ventricular Remodeling | Left Ventricular Diastolic Dysfunction | Inflammatory Myopathy | Fibrosis MyocardialIreland
-
Novartis PharmaceuticalsCompletedHearth Failure With Reduced Ejection Fraction (HFrEF)Canada
-
Novartis PharmaceuticalsWithdrawnPost Myocardial Infarction
-
Novartis PharmaceuticalsCompletedHeart FailureUnited States
-
Novartis PharmaceuticalsCompletedHeart Failure and Reduced Ejection FractionUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedHeart FailureUnited States, Italy, Croatia, India, Japan, Poland, Spain, Taiwan, Austria, Korea, Republic of, Germany, Lebanon, Thailand, Canada, Bulgaria, Russian Federation, Turkey, Switzerland, Argentina, Hungary, Portugal, Finland, South Africa and more
-
Novartis PharmaceuticalsCompletedCardiomyopathy, HypertrophicUnited States, Germany, United Kingdom, Spain, Korea, Republic of, Greece
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
LanZhou UniversityRecruiting
-
Novartis PharmaceuticalsCompletedChronic Heart Failure (CHF)Spain, Croatia, Taiwan, Germany, Italy, United States, Australia, Netherlands, Switzerland, Belgium, United Kingdom, Bulgaria, Lithuania, Russian Federation, France, Argentina, Korea, Republic of, Poland, Canada, Turkey
-
Duke UniversityNovartis PharmaceuticalsCompleted
-
University of ZurichNovartis PharmaceuticalsCompleted
-
Guangdong Provincial People's HospitalUnknownHeart Failure | Hemodialysis ComplicationChina
-
Novartis PharmaceuticalsCompletedHypertensionGermany, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute Myocardial InfarctionChina, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
-
Novartis PharmaceuticalsCompletedMild and Moderate Renal ImpairmentRussian Federation, Germany, Serbia
-
Novartis PharmaceuticalsCompletedHypertension With Renal DysfunctionJapan
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection FractionItaly, Czechia, Russian Federation, Saudi Arabia, Turkey, Belgium, Switzerland, United Kingdom, Spain, Canada, Lebanon, Germany, Slovakia, Portugal, France, Poland, Argentina, Norway, Sweden
-
Novartis PharmaceuticalsNo longer availableHeart Failure With Reduced Ejection Fraction (HF-rEF)Germany, Spain, France, Greece, Lebanon, Austria, Ireland, Slovenia, Australia, Philippines, Brazil, Panama, United States, Croatia, Cyprus, Malta, Switzerland, United Arab Emirates
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionIndia, Romania, Belgium, Czechia, Estonia, Hungary, Russian Federation, Taiwan, United Kingdom, Spain, Israel, Thailand, Canada, Korea, Republic of, United States, Bulgaria, Denmark, Netherlands, Philippines, Lithuania, Germany, T... and more
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection FractionHungary, Spain, Italy, United States, Germany, United Kingdom, Turkey, Slovakia, Bulgaria, Finland, Puerto Rico
-
Novartis PharmaceuticalsCompletedHeart FailureRussian Federation
-
Asan Medical CenterNovartisCompletedMitral Valve Insufficiency | Left Ventricular DysfunctionKorea, Republic of
-
Novartis PharmaceuticalsCompletedSevere HypertensionJapan
-
Novartis PharmaceuticalsActive, not recruitingHeart Failure | Chagas DiseaseBrazil, Argentina, Mexico, Colombia
-
Novartis PharmaceuticalsCompletedSalt-sensitive HypertensionTaiwan, Singapore, United States, Korea, Republic of, Hong Kong
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionChina, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
-
Novartis PharmaceuticalsCompletedHypertensionChina, Taiwan, Japan, Thailand, Korea, Republic of
-
Novartis PharmaceuticalsCompletedHypertensionRussian Federation
-
Novartis PharmaceuticalsCompletedChronic Heart FailurePoland, Netherlands, United States, Argentina, Spain, Singapore, Italy, India, Russian Federation, Canada, Romania, Brazil, Venezuela, Germany
-
Brigham and Women's HospitalNovartis PharmaceuticalsWithdrawnHeart Failure With Reduced Ejection Fraction
-
Novartis PharmaceuticalsCompletedPharmacokinetics | Healthy Volunteer | Renal ImpairedRussian Federation, Germany, Serbia
-
Qingdao Central HospitalNot yet recruitingMyocardial Infarction | HypertensionChina
-
Viatris Inc.Not yet recruiting
-
Novartis PharmaceuticalsCompletedHypertensionSpain, Italy, Netherlands, United States, Denmark, Taiwan, Argentina, Germany, Russian Federation, Slovakia, Canada, Hungary, Latvia, Lithuania, Poland, Finland, France, Sweden
-
Novartis PharmaceuticalsCompletedSystolic HypertensionUnited States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
-
Damanhour UniversityTanta UniversityCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Spain, Philippines, Guatemala, Russian Federation, Argentina, Puerto Rico
-
Novartis PharmaceuticalsCompletedEssential HypertensionChina, Korea, Republic of, Taiwan, Hong Kong, Thailand, Philippines, Singapore
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Hypertension | Obesity | Nocturnal Blood Pressure | Natriuretic Peptides | Renin-Angiotensin-Aldosterone SystemUnited States
-
Bio-innova Co., LtdNot yet recruiting